等待开盘 12-20 09:30:00 美东时间
+0.080
+0.20%
Terns Pharma presented positive data from ongoing CARDINAL trial of TERN-701 in CML patients, showing high MMR rates and good safety profile.
12-09 20:51
Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage oncology company, today announced that it has commenced a proposed underwritten public offering of $400 million of shares of its
12-09 19:20
William Blair analyst Andy Hsieh upgrades Terns Pharma (NASDAQ:TERN) from Market Perform to Outperform.
11-04 05:24
(来源:开源证券研究所) 减重降糖赛道一直是近年来最受关注的创新药研发领域之一,以司美格鲁肽、替尔泊肽为代表的GLP-1受体激动剂类药物正在彻底改变肥胖...
09-18 08:01
开源证券发布研报称,小分子GLP-1RA有望为减重降糖市场提供新的增量空间。礼来的Orforglipron是全球进度最快的小分子GLP-1RA产品,目前针对多个...
09-03 09:34
来源:上海证券报·中国证券网 上证报中国证券网讯(年悦 记者 张雪)天津上市公司2025年上半年业绩表现亮眼,多家企业实现利润稳定增长,恒银科技、赛诺医疗等公司...
09-01 20:03
8月18日消息,南玻A公告显示,截止2025年6月30日,相较于上一报告期,十大流通股东发生了以下变化:1位股东新进,1位股东退出,2位股东减持。 新进的流通股...
08-18 22:10
转自:贝壳财经 自2021年11月签署上市辅导协议后,一纸公告为兰亭科技的IPO征程暂时画上句号。7月28日,新京报贝壳财经记者获悉,深圳市兰亭科技股份有限公司...
08-01 13:25
Terns Pharmaceuticals' senior management will participate in two upcoming investor conferences in June: the Jefferies Global Healthcare Conference on June 5 in New York City and the Goldman Sachs 46th Annual Global Healthcare Conference on June 9 in Miami. Both events will feature fireside chats available via live webcast on the company's investor relations page, with replays archived for 30 days.
05-29 20:05